To include your compound in the COVID-19 Resource Center, submit it here.

Editing translation

How some Cas9s can edit RNA targets

CRISPR pioneer Jennifer Doudna has expanded the technology’s reach to diseases involving RNA targets with a new publication showing at least two of the CRISPR-based systems used to edit nuclear DNA can also bind and cleave cytosolic RNA.

In an eLife paper this month, Doudna and colleagues at the University of California Berkeley showed that CRISPR-associated protein 9 (Cas9)

Read the full 581 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers